請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/58815完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 鄭守夏 | |
| dc.contributor.author | Ming-Hua Yu | en |
| dc.contributor.author | 游明樺 | zh_TW |
| dc.date.accessioned | 2021-06-16T08:32:36Z | - |
| dc.date.available | 2014-02-25 | |
| dc.date.copyright | 2014-02-25 | |
| dc.date.issued | 2014 | |
| dc.date.submitted | 2013-12-12 | |
| dc.identifier.citation | 中央健保局(2012)，http://www.nhi.gov.tw/。
監察院(2012)，101000290安眠藥調查報告，監察院公開報告書。 王元甫(2008)，新一代安眠藥仍須小心使用，元甫醫學園地，http://www.epochtimes.com/b5/8/4/7/n2073490.htm。 台灣大學藥學系。 朱璿尹、鄭守夏(2011)，照護連續性與潛在不適當用藥相關性探討，臺灣大學健康政策與管理研究所碩士論文。 吳欣諭、鄭守夏(2010)，照護連續性與民眾逛醫師行為之相關性探討，臺灣大學健康政策與管理研究所碩士論文。 李謀進(2011)，全民健保政策對藥品生命週期的影響 — 以Cefamezin, Stilnox為例，藥學雜誌， 27(1)，29-33。 邱南英(2006)，安眠藥物Zolpidem 使用爭議的案例探討，醫療爭議審議報導 郁弘、蔡東榮(2009)，失眠門診病人使用安眠藥品之處方型態與趨勢分析，高雄醫學大學藥學研究所碩士在職專班碩士論文。 高純琇(2008)，臨床藥學研究及健保資料庫的運用，財團法人醫藥品查驗中心/ 張瑞益、邱尚志(2012)，新罹患癌症病人逛醫院行為之資源耗用探討-以肝癌、直腸癌為例，衛生署2010年度委託研究計畫。 許育彰、鄭守夏、黃文鴻(1998)，健保門診非成癮性止痛藥處方型態分析及處方問題探討，臺灣大學衛生政策與管理研究所碩士論文。 郭巧儀、李丞華(2004)，多醫就診者之醫療利用及其影響因素，國立陽明大學醫務管理碩士論文。 溫劭宜、吳淑瓊(2006)，台灣失能老人安眠藥使用情形與相關因素探討，臺灣大學衛生政策與管理研究所碩士論文。 劉雅文、楊銘欽(2008)，以2005年承保抽樣歸人檔分析高血壓病人之重複醫療資源利用情形，臺灣大學醫療機構管理研究所學位論文。 潘建宇、譚秀芬(2007)，國內BZD類鎮靜安眠藥處方情形評估，長榮大學醫務管理學研究所碩士論文。 鄭淑文、楊瑛碧(2009)，精神科門診Benzodiazepines (BZDs)使用現況初探，藥學雜誌，25(4)，118-125。 賴奕菁(2012)，鎮靜安眠藥品處方型態之趨勢分析及合理性評估，衛生署2010年度委託研究計畫。 賴奕菁、陳姿婷(2012)，2000至2007年間「非苯二氮平」類管制安眠藥品於「苯二氮平指引」實施前後其處方型態之趨勢分析比較，衛生署2009年度委託研究計畫。 賴奕菁、黃文鴻(2003)，門診老年失眠症患者之安眠藥處方型態及處方問題，陽明大學衛生福利所碩士論文。 謝明珠、文羽苹(2008)，台灣鎮靜安眠藥物使用者特質與就醫領藥分析，長庚大學醫務管理學研究所碩士論文。 謝斯婷、高雅慧、林文亮(2010)，長期使用Benzodiazepines 與劑量變化之探討，成功大學臨床藥學研究所。 Adler, R., Vasiliadis, A., & Bickell, N. (2010). The relationship between continuity and patient satisfaction: a systematic review. Family Practice, 27(2), 171-178. doi: DOI 10.1093/fampra/cmp099 Agarwal, G., & Crooks, V. A. (2008). The nature of informational continuity of care in general practice. British Journal of General Practice, 58(556), 784-789. doi: DOI 10.3399/bjgp08X342624 Andersen, A. B. T., & Frydenberg, M. (2011). Long-term use of zopiclone, zolpidem and zaleplon among Danish elderly and the association with sociodemographic factors and use of other drugs. Pharmacoepidemiology and Drug Safety, 20(4), 378-385. doi: Doi 10.1002/Pds.2104 Bice, T. W., & Boxerman, S. B. (1977). A quantitative measure of continuity of care. Med Care, 15(4), 347-349. Blanco, C., Alderson, D., Ogburn, E., Grant, B. F., Nunes, E. V., Hatzenbuehler, M. L., & Hasin, D. S. (2007). Changes in the prevalence of non-medical prescription drug use and drug use disorders in the United States: 1991-1992 and 2001-2002. [Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't]. Drug Alcohol Depend, 90(2-3), 252-260. doi: 10.1016/j.drugalcdep.2007.04.005 Busto, U., Sellers, E. M., Naranjo, C. A., Cappell, H. D., Sanchez-Craig, M., & Simpkins, J. (1986). Patterns of benzodiazepine abuse and dependence. Br J Addict, 81(1), 87-94. Buurma, H., Bouvy, M. L., De Smet, P. A., Floor-Schreudering, A., Leufkens, H. G., & Egberts, A. C. (2008). Prevalence and determinants of pharmacy shopping behaviour. Journal of Clinical Pharmacy and Therapeutics, 33(1), 17-23. doi: 10.1111/j.1365-2710.2008.00878.x Carter, L. P., & Griffiths, R. R. (2009). Principles of laboratory assessment of drug abuse liability and implications for clinical development. Drug and Alcohol Dependence, 105, S14-S25. doi: DOI 10.1016/j.drugalcdep.2009.04.003 Charlson, M. E., Pompei, P., Ales, K. L., & Mackenzie, C. R. (1987). A New Method of Classifying Prognostic Co-Morbidity in Longitudinal-Studies - Development and Validation. Journal of Chronic Diseases, 40(5), 373-383. doi: Doi 10.1016/0021-9681(87)90171-8 Cheng, J. S., Huang, W. F., Lin, K. M., & Shih, Y. T. (2008). Characteristics associated with benzodiazepine usage in elderly outpatients in Taiwan. International Journal of Geriatric Psychiatry, 23(6), 618-624. doi: Doi 10.1002/Gps.1950 Cyr, M. C., Martens, A. C., Berbiche, D., Perreault, S., & Blais, L. (2006). Continuity of care in the ambulatory treatment of adolescents with asthma. [Comparative Study Research Support, Non-U.S. Gov't]. J Adolesc Health, 39(6), 926 e911-927. doi: 10.1016/j.jadohealth.2006.06.013 Dart, R. C. (2009). Monitoring risk: post marketing surveillance and signal detection. [Research Support, Non-U.S. Gov't]. Drug Alcohol Depend, 105 Suppl 1, S26-32. doi: 10.1016/j.drugalcdep.2009.08.011 Deyo, R. A., Cherkin, D. C., & Ciol, M. A. (1992). Adapting a Clinical Comorbidity Index for Use with Icd-9-Cm Administrative Databases. Journal of Clinical Epidemiology, 45(6), 613-619. doi: Doi 10.1016/0895-4356(92)90133-8 Fang, H., & Rizzo, J. A. (2009). Competition and physician-enabled demand: The role of managed care. Journal of Economic Behavior & Organization, 72(1), 463-474. doi: DOI 10.1016/j.jebo.2009.05.012 Fisher, J., Sanyal, C., Frail, D., & Sketris, I. (2012). The intended and unintended consequences of benzodiazepine monitoring programmes: a review of the literature. [Review]. Journal of Clinical Pharmacy and Therapeutics, 37(1), 7-21. doi: 10.1111/j.1365-2710.2011.01245.x Griffiths, R. R., & Johnson, M. W. (2005). Relative abuse liability of hypnotic drugs: A conceptual framework and algorithm for differentiating among compounds. Journal of Clinical Psychiatry, 66, 31-41. Haggerty, J. L., Reid, R. J., Freeman, G. K., Starfield, B. H., Adair, C. E., & McKendry, R. (2003). Continuity of care: a multidisciplinary review. [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.Review]. BMJ, 327(7425), 1219-1221. doi: 10.1136/bmj.327.7425.1219 Hansen, G. R. (2005). The drug-seeking patient in the emergency room. Emergency Medicine Clinics of North America, 23(2), 349-+. doi: DOI 10.1016/j.emc.2004.12.006 Hoque, R., & Chesson, A. L., Jr. (2009). Zolpidem-induced sleepwalking, sleep related eating disorder, and sleep-driving: fluorine-18-flourodeoxyglucose positron emission tomography analysis, and a literature review of other unexpected clinical effects of zolpidem. [Case Reports Review]. J Clin Sleep Med, 5(5), 471-476. Hou, C. C., Chen, S. C., Tan, L. B., Chu, W. Y., Huang, C. M., Liu, S. Y., & Chen, K. T. (2012). Psychoactive Substance Use and the Risk of Motor Vehicle Crash Injuries in Southern Taiwan. Prevention Science, 13(1), 36-42. doi: DOI 10.1007/s11121-011-0242-5 Inciardi, J. A., Surratt, H. L., Kurtz, S. P., & Cicero, T. J. (2007). Mechanisms of prescription drug diversion among drug-involved club- and street-based populations. Pain Medicine, 8(2), 171-183. doi: DOI 10.1111/j.1526-4637.2006.00255.x Isacson, D. (1997). Long-term benzodiazepine use: factors of importance and the development of individual use patterns over time--a 13-year follow-up in a Swedish community. Soc Sci Med, 44(12), 1871-1880. Jee, S. H., & Cabana, M. D. (2006). Indices for continuity of care: A systematic review of the literature. Medical Care Research and Review, 63(2), 158-188. doi: Doi 10.1177/1077558705285294 Kasteler, J., Kane, R. L., Olsen, D. M., & Thetford, C. (1976). Issues Underlying Prevalence of Doctor-Shopping Behavior. Journal of Health and Social Behavior, 17(4), 328-339. Kerr, J., Walsh, A. E., Konkin, J., Tannenbaum, D., Organek, A. J., Parsons, E., . . . Oandasan, I. (2011). Continuity: middle C-a very good place to start. Canadian Family Physician, 57(11), 1355-1356. Kripke, D. F., Langer, R. D., & Kline, L. E. (2012). Hypnotics' association with mortality or cancer: a matched cohort study. BMJ Open, 2(1), e000850. doi: 10.1136/bmjopen-2012-000850Lader, M., Tylee, A., & Donoghue, J. (2009). Withdrawing benzodiazepines in primary care. [Research Support, Non-U.S. Gov'tReview]. CNS Drugs, 23(1), 19-34. doi: 0.2165/0023210-200923010-00002 Lagnaoui, R., Depont, F., Fourrier, A., Abouelfath, A., Begaud, B., Verdoux, H., & Moore, N. (2004). Patterns and correlates of benzodiazepine use in the French general population. Eur J Clin Pharmacol, 60(7), 523-529. doi: DOI 10.1007/s00228-004-0808-2 Lai, I. C., Wang, M. T., Wu, B. J., Wu, H. H., & Lian, P. W. (2011). The use of benzodiazepine monotherapy for major depression before and after implementation of guidelines for benzodiazepine use. Journal of Clinical Pharmacy and Therapeutics, 36(5), 577-584. doi: DOI 10.1111/j.1365-2710.2010.01213.x Lin, S. C., Chen, C. C., Chen, Y. H., Chung, K. S., & Lin, C. H. (2011). Benzodiazepine prescription among patients with severe mental illness and co-occurring alcohol abuse/dependence in Taiwan. Human Psychopharmacology-Clinical and Experimental, 26(3), 201-207. doi: Doi 10.1002/Hup.1193 Liu, X., Ye, W. Y., Watson, P., & Tepper, P. (2010). Use of Benzodiazepines, Hypnotics, and Anxiolytics in Major Depressive Disorder Association With Chronic Pain Diseases. Journal of Nervous and Mental Disease, 198(8), 544-550. doi: Doi 10.1097/Nmd.0b013e3181e9daf7 Maizes, V., Rakel, D., & Niemiec, C. (2009). Integrative medicine and patient-centered care. [Case Reports Historical Article Review]. Explore (NY), 5(5), 277-289. doi: 10.1016/j.explore.2009.06.008 Manchikanti, L. (2007). National drug control policy and prescription drug abuse: facts and fallacies. [Review]. Pain Physician, 10(3), 399-424. Martyres, R. F., Clode, D., & Burns, J. M. (2004). Seeking drugs or seeking help? Escalating 'doctor shopping' by young heroin users before fatal overdose. [Research Support, Non-U.S. Gov't]. Med J Aust, 180(5), 211-214. McCabe, S. E. (2005). Correlates of nonmedical use of prescription benzodiazepine anxiolytics: results from a national survey of US college students. Drug and Alcohol Dependence, 79(1), 53-62. doi: DOI 10.1016/j.drugalcdep.2004.12.006 McCabe, S. E., Boyd, C. J., & Teter, C. J. (2009). Subtypes of nonmedical prescription drug misuse. Drug and Alcohol Dependence, 102(1-3), 63-70. doi: DOI 10.1016/j.drugalcdep.2009.01.007 McCarthy, M. (2007a). Prescription drug abuse up sharply in the USA. Lancet, 369(9572), 1505-1506. McCarthy, M. (2007b). Prescription drug abuse up sharply in the USA. [News]. Lancet, 369(9572), 1505-1506. doi: 10.1016/S0140-6736(07)60690-4 Monheit, B. (2010). Prescription drug misuse. Australian Family Physician, 39(8), 540-546. Oster, G., Huse, D. M., Adams, S. F., Imbimbo, J., & Russell, M. W. (1990). Benzodiazepine Tranquilizers and the Risk of Accidental Injury. American Journal of Public Health, 80(12), 1467-1470. Pradel, V., Delga, C., Rouby, F., Micallef, J., & Lapeyre-Mestre, M. (2010). Assessment of abuse potential of benzodiazepines from a prescription database using 'doctor shopping' as an indicator. CNS Drugs, 24(7), 611-620. doi: 10.2165/11531570-000000000-00000 Pradel, V., Frauger, E., Thirion, X., Ronfle, E., Lapierre, V., Masut, A., . . . Micallef, J. (2009). Impact of a prescription monitoring program on doctor-shopping for high dosage buprenorphine. Pharmacoepidemiology and Drug Safety, 18(1), 36-43. doi: Doi 10.1002/Pds.1681 Pressman, M. R. (2011). Sleep driving: sleepwalking variant or misuse of z-drugs? [Review]. Sleep Med Rev, 15(5), 285-292. doi: 10.1016/j.smrv.2010.12.004 Rockett, I. R. H., Putnam, S. L., Jia, H. M., & Smith, G. S. (2003). Assessing substance abuse treatment need: A statewide hospital emergency department study. Annals of Emergency Medicine, 41(6), 802-813. doi: Doi 10.1067/Mem.2003.189 Rouby, F., Pradel, V., Frauger, E., Pauly, V., Natali, F., Reggio, P., . . . Micallef, J. (2012). Assessment of abuse of tianeptine from a reimbursement database using doctor-shopping' as an indicator. Fundam Clin Pharmacol, 26(2), 286-294. doi: DOI 10.1111/j.1472-8206.2010.00906.x Salzman, C. (1991). The Apa Task-Force Report on Benzodiazepine Dependence, Toxicity, and Abuse. American Journal of Psychiatry, 148(2), 151-152. Schneider, M. F., Bailey, J. E., Cicero, T. J., Dart, R. C., Inciardi, J. A., Parrino, M., & Munoz, A. (2009). Integrating nine prescription opioid analgesics and/or four signal detection systems to summarize statewide prescription drug abuse in the United States in 2007. Pharmacoepidemiology and Drug Safety, 18(9), 778-790. doi: Doi 10.1002/Pds.1780 Schomerus, G., Matschinger, H., & Angermeyer, M. C. (2009). The stigma of psychiatric treatment and help-seeking intentions for depression. European Archives of Psychiatry and Clinical Neuroscience, 259(5), 298-306. doi: DOI 10.1007/s00406-009-0870-y Sheridan, J., & Butler, R. (2011). Prescription drug misuse in New Zealand: Challenges for primary health care professionals. Research in Social & Administrative Pharmacy, 7(3), 281-293. doi: DOI 10.1016/j.sapharm.2010.06.005 Sonnenberg, C. M., Bierman, E. J. M., Deeg, D. J. H., Comijs, H. C., van Tilburg, W., & Beekman, A. T. F. (2012). Ten-year trends in benzodiazepine use in the Dutch population. Social Psychiatry and Psychiatric Epidemiology, 47(2), 293-301. doi: DOI 10.1007/s00127-011-0344-1 Spanemberg, L., Nogueira, E. L., da Silva, C. T., Dargel, A. A., Menezes, F. S., & Cataldo Neto, A. (2011). High prevalence and prescription of benzodiazepines for elderly: data from psychiatric consultation to patients from an emergency room of a general hospital. [Comparative Study]. Gen Hosp Psychiatry, 33(1), 45-50. doi: 10.1016/j.genhosppsych.2010.12.004 Stevens, J. C., & Pollack, M. H. (2005). Benzodiazepines in clinical practice: Consideration of their long-term use and alternative agents. Journal of Clinical Psychiatry, 66, 21-27. Tsai, J. H., Yang, P., Chen, C. C., Chung, W., Tang, T. C., Wang, S. Y., & Liu, J. K. (2009). Zolpidem-induced amnesia and somnambulism: rare occurrences? Eur Neuropsychopharmacol, 19(1), 74-76. doi: 10.1016/j.euroneuro.2008.08.007 Victorri-Vigneau, C., Dailly, E., Veyrac, G., & Jolliet, P. (2007). Evidence of zolpidem abuse and dependence: results of the French Centre for Evaluation and Information on Pharmacodependence (CEIP) network survey. British Journal of Clinical Pharmacology, 64(2), 198-209. doi: DOI 10.1111/j.1365-2125.2007.02861.x Voshaar, R. C. O., Couvee, J. E., Van Balkom, A. J. L. M., Mulder, P. G. H., & Zitman, F. G. (2006). Strategies for discontinuing long-term benzodiazepine use - Meta-analysis. British Journal of Psychiatry, 189, 213-220. doi: DOI 10.1192/bjp.189.3.213 Voyer, P., Preville, M., Roussel, M. E., Berbiche, D., & Beland, S. G. (2009). Factors Associated With Benzodiazepine Dependence Among Community-Dwelling Seniors. Journal of Community Health Nursing, 26(3), 101-113. doi: Pii 913731665 Doi 10.1080/07370010903034375 Wang, J., & Christo, P. J. (2009). The influence of prescription monitoring programs on chronic pain management. Pain Physician, 12(3), 507-515. Wang, M. J., & Lin, S. P. (2010). Study on doctor shopping behavior: insight from patients with upper respiratory tract infection in Taiwan. Health Policy, 94(1), 61-67. doi: 10.1016/j.healthpol.2009.08.009 Zarocostas, J. (2010). Countries face 'hidden problem' of prescription drug misuse. British Medical Journal, 340. doi: Artn C1109 Doi 10.1136/Bmj.C1109 Zechnich, A. D., & Hedges, J. R. (1996). Community-wide emergency department visits by patients suspected of drug-seeking behavior. Academic Emergency Medicine, 3(4), 312-317. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/58815 | - |
| dc.description.abstract | 背景:
處方藥濫用是近年重要的公衛問題，其中，逛醫生(doctor shopping)被視為嚴重的處方藥物濫用行為，許多人可能會藉逛醫生重複領取同樣的藥物，也就是所謂的尋藥行為。而安眠鎮靜成份之一的Zolpidem，在台灣的成癮或濫用性逐年上升，因此，我們將利用重複領藥比例(DSI)計算民眾可能存在的Zolpidem尋藥行為。另一方面，照護連續性是測量民眾初級醫療利用很好的指標，所以我們也將分析照護連續性對於尋藥行為的影響。 目的: 探討台灣Zolpidem重複領藥的情形，並分析尋藥行為者的特質和相關影響因素，此外，比較非使用者、一般使用者和尋藥者其醫療利用的差異情形，和照護連續性對其的影響。 方法 本研究利用健保資料庫調查民眾領取Zolpidem的情形和尋藥行為，並計算使用者的重複領藥比例，其中我們也將利用傾向分數配對方法提高對照組和研究組的可比較性，藉由多元羅吉斯迴歸(Multinomial logistic regression)瞭解非使用者、一般使用者和尋藥者的差異，最後我們採COCI計算方式，分析照護連續性對使用者的影響。 結果: 2009年領取Zolpidem的盛行率為3.58%，重複領藥比例為7.54%，其中尋藥者重複領藥比例高達27.8%，影響青壯年和中年尋藥者的因子為，慢性病越多和投保薪資越低者其領取Zolpidem的機率也越高，而尋藥者在家醫科和內科的使用量皆比其他人高，老人方面的尋藥影響因素則是，慢性病越多和所在的醫師密度越高，其領取Zolpidem的情形越高，他們在內科和家醫科的利用則無達到統計上差異。最後，照護連續性對於尋藥者的影響程度，比起一般使用者對比無使用者的影響力更大，且隨著年齡越高，照護連續性對其的影響程度也越大，尤其是老年族群。 結論: Zolpidem尋藥行為確實存在，且不同年齡層有不同的影響因素，而民眾在非精神專科的領藥比例也應加強重視，若能提高照護連性將有助於減少此行為的產生，建議有關單位應重視國內尋藥行為的現象，並進一步的做深入了解。 | zh_TW |
| dc.description.abstract | Background: Prescription drug abuse is one of the important problems in public health, and among which, doctor shopping is regarded as a serious behavior. Many people may get the same prescription drugs through different doctors repeatedly, which is called drug-seeking behavior. Zolidem, a prescription medication used for the treatment of insomnia, has been abused in Taiwan recently. This study aims to explore how drug-seekers get Zolpidem and the relevant factors associated with their consumption. We use a new method to estimate the relative parts of legitimate prescriptions and doctor shopping on the prescription database of NHI. Additionly, we also examine the connection between continuity of care(COC) and drug-seeking behavior.
Objective: We use doctor shopping indicator (DSI) to calculate the potential drug-seeking behaviors of Zolpidem in Taiwan. Besides, we want to understand the influence of COC on drug-seeking behavior. Methods: We extract all the prescriptions of Zolpidem from National Health Insurance Registry of 2009. Moreover, we use propensity score matching (PSM) to reduce the bias between treatment and control groups on a large number of covariates. We profile the factors influencing non-users, users, and drug seekers with multinomial logistic regression. Results: A total of 29,207 users are included in this study and the DSI is 7.54%. There are 2,420 persons who have drug-seeking behavior and their DSI is 27.8%. However, compared with people who don’t have this behavior, their DSI is only 0.5%. The result of logistic regression shows that Charlson comorbidity index and insurance degree are two factors significantly associated with the use of Zolpidem for the young and middle-aged drug-seekers. The drug-seekers of Family Medicine and General Medicine get more Zolpidem than other people. For elders, Charlson comorbidity index and density of doctors are two important factors significantly associated with the use of Zolpidem. Besides, higher COC indices are associated with lower prescription drug abuse, especially for the elders. Conclusions: Drug-seeking behavior is increasing in Taiwan, which may cause serious prescription drug abuse problems. Health policymakers and the academic communities should begin to investigate the drug-seekers’ purposes and the possible effects of drug-seeking behavior on their health. Additionally, we should develop new regulatory guides and prescription monitoring programs for their abuse. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-16T08:32:36Z (GMT). No. of bitstreams: 1 ntu-103-R00848002-1.pdf: 1380480 bytes, checksum: 286ac8fe12a4aa092ab40a056e6c7dcf (MD5) Previous issue date: 2014 | en |
| dc.description.tableofcontents | 摘要 I
目錄 V 圖目錄 VII 表目錄 VIII 第一章 緒論 1 第一節、研究背景與動機 1 第二節、研究目的 3 第三節、研究重要性 3 第二章 文獻回顧 4 第一節、處方藥濫用與尋藥行為 4 第二節、安眠藥危害與使用情形 7 第三節、介入政策與監控系統 14 第四節、重複領藥比例與照護連續性 15 第五節、文獻小結 19 第三章 研究方法與材料 20 第一節、研究對象與研究架構 20 第二節、資料處理流程 22 第三節、操作型定義 24 第四節、研究假說 30 第五節、統計分析 30 第四章 研究結果 31 第一節、配對前後樣本特質 31 第二節、重複領藥比例和尋藥傾向 36 第三節、照護連續性影響 46 第五章 討論 50 第一節、研究設計與方法 50 第二節、使用者特質與重複領藥 53 第三節、尋藥行為與影響因素 55 第四節、照護連續性與介入政策 58 第五節、研究限制 61 第六章 結論與建議 62 第一節、結論 62 第二節、建議 63 參考文獻 65 附錄 73 | |
| dc.language.iso | zh-TW | |
| dc.title | 台灣民眾逛醫師尋藥行為之初探－以鎮靜安眠藥Zolpidem為例 | zh_TW |
| dc.title | A Preliminary Evaluation of Drug-seeking Behavior in Taiwan: The Case of Zolpidem | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 102-1 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 楊銘欽,文羽苹 | |
| dc.subject.keyword | 尋藥行為,重複領藥比例,逛醫生,處方藥濫用,史蒂諾斯, | zh_TW |
| dc.subject.keyword | drug seeking behavior,doctor-shopping indicator,doctor shopping,prescription drug abuse,Zolpidem, | en |
| dc.relation.page | 80 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2013-12-13 | |
| dc.contributor.author-college | 公共衛生學院 | zh_TW |
| dc.contributor.author-dept | 健康政策與管理研究所 | zh_TW |
| 顯示於系所單位： | 健康政策與管理研究所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-103-1.pdf 目前未授權公開取用 | 1.35 MB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。